Skip to main content
. 2019 Aug 9;4(12):1748–1751. doi: 10.1016/j.ekir.2019.07.022

Table 1.

Baseline characteristics by quartiles of FGF23

Variablea Full cohort Quartile 1 Quartile 2 Quartile 3 Quartile 4
N 47 9 12 14 12
iFGF23 (pg/ml) 32–361 363–1074 1195–3195 3926–22,369
Age (yr) 61 (±20) 66 (±22) 57 (±18) 55 (±18) 68 (±21)
Weight (kg) 68 (±18) 61 (±16) 80 (±18) 66 (±19) 63 (±12)
Male (%) 70 67 75 64 75
EF ≥ 50%, n (%) 29 (62) 5 (56) 9 (75) 10 (71) 5 (42)
LV hypertrophyb n (%) 25 (53) 4 (44) 5 (42) 6 (43) 10 (83)
TR jet velocity (cm/s) 2.6 (±0.5) 2.5 (±0.7) 2.3 (±0.3) 2.7 (±0.3) 2.9 (±0.3)
E to A ratioc 1.4 (±0.5) 0.9 (±0.4) 1.1 (±0.6) 1.5 (±0.6) 2.1 (±0.4)
LA volume (ml) 58 (±27) 56 (±24) 55 (±25) 55 (±21) 65 (±37)
Hemoglobin (g/dl) 11.7 (±1.4) 11.4 (±1.0) 11.4 (±1.0) 12.2 (±1.5) 11.5 (±1.7)
Calcium (mg/dl) 8.6 (±0.7) 8.5 (±0.5) 8.6 (±0.4) 8.6 (±0.7) 8.6 (±0.9)
Phosphate (mg/dl) 5 (±1.4) 3.9 (±0.8) 4.7 (±1.0) 5.4 (±1.3) 5.8 (±1.7)

EF, ejection fraction; iFGF, intact fibroblast growth factor; LA, left atrium; LV, left ventricle; TR, tricuspid regurgitation

a

Data are reported as mean (±SD) for continuous variables, and % for categorical variables.

b

Left ventricular wall thickness >11 mm is defined as LV hypertrophy.

c

E (transmitral early filling velocity) / A (transmitral late filling velocity) ratio.